Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: Role of transforming growth factor-β1

Cardiovascular Research

Volumn 74, Issue 2, 2007, Pages 270-278

  Eligini, Sonia ^a   Barbieri, Silvia S ^a   Arenaz, Izaskun ^a   Tremoli, Elena ^a   Colli, Susanna ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cyclooxygenase; Growth factors; MAP kinase; Monocytes; Platelets

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; THROMBOXANE A2; THROMBOXANE B2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL ADHESION; CELL GRANULE; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME INDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; TISSUE REPAIR; UPREGULATION; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOTTING, WESTERN; CELL ADHESION; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; MONOCYTES; PARACRINE COMMUNICATION; PLATELET ACTIVATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOXANE B2; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; WOUND HEALING;

EID: 34047148353     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.12.013     Document Type: Article

References (55)

1. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L., Van De Putte L.B., et al. Cyclooxygenase in biology and disease. FASEB J 12 (1998) 1063-1073
2. Beloqui O., Paramo J.A., Orbe J., Benito A., Colina I., Monasterio A., et al. Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?. Eur Heart J 26 (2005) 153-158
3. Cipollone F., Fazia M.L., Iezzi A., Cuccurullo C., De Cesare D., Ucchino S., et al. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol 25 (2005) 1925-1931
4. Takayama K., Garcia-Cardena G., Sukhova G.K., Comander J., Gimbrone Jr. M.A., and Libby P. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 277 (2002) 44147-44154
5. Weyrich A.S., and Zimmerman G.A. Platelets: signaling cells in the immune continuum. Trends Immunol 25 (2004) 389-495
6. Gawaz M., Langer H., and May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 115 (2005) 3378-3384
7. Weyrich A.S., Denis M.M., Kuhlmann-Eyre J.R., Spencer E.D., Dixon D.A., Marathe G.K., et al. Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation 111 (2005) 633-642
8. Barry O.P., Kazanietz M.G., Praticò D., and FitzGerald G.A. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 274 (1999) 7545-7556
9. Weyrich A.S., Lindemann S., and Zimmerman G.A. The evolving role of platelets in inflammation. J Thromb Haemost 1 (2003) 1897-1905
10. Rendu F., and Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 12 (2001) 261-273
11. McIntyre T.M., Prescott S.M., Weyrich A.S., and Zimmerman G.A. Cell-cell interactions: leukocyte-endothelial interactions. Curr Opin Hematol 10 (2003) 150-158
12. Anitua E., Andia I., Ardanza B., Nurden P., and Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91 (2004) 4-15
13. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGF-beta. Annu Rev Immunol 16 (1998) 137-161
14. Wiseman D.M., Polverini P.J., Kamp D.W., and Leibovich S.J. Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 15 157 (1988) 793-800
15. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 84 (1987) 5788-5792
16. Wahl S.M., Allen J.B., Weeks B.S., Wong H.L., and Klotman P.E. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci U S A 90 (1993) 4577-4581
17. Brunner G., and Blakytny R. Extracellular regulation of TGF-beta activity in wound repair: growth factor latency as a sensor mechanism for injury. Thromb Haemost 92 (2004) 253-261
18. Mehta J.L., Yang B.C., Strates B.S., and Mehta P. Role of TGF-beta1 in platelet-mediated cardioprotection during ischemia-reperfusion in isolated rat hearts. Growth Factors 16 (1999) 179-190
19. Bobik A. Transforming growth factor-βs and vascular disorders. Arterioscler Thromb Vasc Biol 26 (2006) 1712-1720
20. Tremoli E., Eligini S., Colli S., Maderna P., Risè P., Pazzucconi F., et al. N-3 fatty acid ethyl ester administration to healthy subjects and to hypertrigliceridemic patients reduces tissue factor activity in adherent monocytes. Arterioscler Thromb 14 (1994) 1600-1608
21. Eligini S., Colli S., Basso F., Sironi L., and Tremoli E. Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages. Arterioscler Thromb Vasc Biol 19 (1999) 1719-1725
22. Barbieri S.S., Eligini S., Brambilla M., Tremoli E., and Colli S. Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase. Cardiovasc Res 60 (2003) 187-197
23. Allan C.J., and Halushka P.V. Characterization of human peripheral blood monocyte thromboxane A2 receptors. J Pharmacol Exp Ther 270 (1994) 446-452
24. Caughey G.E., Cleland L.G., Gamble J.R., and James M.J. Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2. J Biol Chem 276 (2001) 37839-37845
25. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 1 (2003) 1655-1662
26. Kunzelmann-Marche C., Freyssinet J.M., and Martinez M.C. Regulation of phosphatidylserine transbilayer redistribution by store-operated Ca2+ entry: role of actin cytoskeleton. J Biol Chem 276 16 (2001) 5134-5139
27. Gemmell C.H., Sefton M.V., and Yeo E.L. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem 268 (1993) 14586-14589
28. Scarborough R.M. Development of eptifibatide. Am Heart J 138 (1999) 1093-1104
29. Rinder C.S., Student L.A., Bonan J.L., Rinder H.M., and Smith B.R. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood 82 (1993) 505-512
30. Ilveskero S., and Lassila R. Abciximab inhibits procoagulant activity but not the release reaction upon collagen- or clot-adherent platelets. J Thromb Haemost 1 (2003) 805-813
31. Hjelmeland M.D., Hjelmeland A.B., Sathornsumetee S., Reese E.D., Herbstreith M.H., Laping N.J., et al. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther 3 (2004) 737-745
32. Blakytny R., Ludlow A., Martin G.E., Ireland G., Lund L.R., Ferguson M.W., et al. Latent TGF-beta1 activation by platelets. J Cell Physiol 199 (2004) 67-76
33. Lindemann S., Tolley N.D., Dixon D.A., McIntyre T.M., Prescott S.M., Zimmerman G.A., et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis. J Cell Biol 154 (2001) 485-490
34. Schini-Kerth V.B., Bassus S., Fisslthaler B., Kirchmaier C.M., and Busse R. Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-beta1 and platelet-derived growth factorAB. Circulation 96 (1997) 3888-3896
35. Baker C.S., Hall R.J., Evans T.J., Pomerance A., Maclouf J., Creminon C., et al. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol 19 (1999) 646-655
36. Schonbeck U., Sukhova G.K., Graber P., Coulter S., and Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155 (1999) 1281-1291
37. James M.J., Penglis P.S., Caughey G.E., Demasi M., and Cleland L.G. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?. Inflamm Res 50 (2001) 249-253
38. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., and Sporn M.B. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258 (1983) 7155-7160
39. Fong C.Y., Pang L., Holland E., and Knox A.J. TGF-beta1 stimulates IL-8 release, COX-2 expression, and PGE(2) release in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 279 (2000) L201-L207
40. Bradbury D.A., Newton R., Zhu Y.M., Stocks J., Corbett L., Holland E.D., et al. Effect of bradykinin, TGF-beta1, IL-1beta, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283 (2002) L717-L725
41. Harding P., Balasubramanian L., Swegan J., Stevens A., and Glass II W.F. Transforming growth factor beta regulates cyclooxygenase-2 in glomerular mesangial cells. Kidney Int 69 (2006) 1578-1585
42. von Knethen A., Callsen D., and Brune B. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol 163 (1999) 2858-2866
43. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., and O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109 (2002) 1405-1415
44. Ghayor C., Rey A., and Caverzasio J. Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor beta in mouse osteoblastic cells. Bone 36 (2005) 93-100
45. Weyrich A.S., Elstad M.R., McEver R.P., McIntyre T.M., Moore K.L., Morrissey J.K., et al. Activated platelets signal chemokine synthesis by human monocyte. J Clin Invest 97 (1996) 1525-1534
46. Dixon D.A., Tolley N.D., Bemis-Standoli K., Martinez M.L., Weyrich A.S., Morrow J.D., et al. Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest 116 (2006) 2727-2738
47. Stamp L.K., James M.J., and Cleland L.G. Paracrine upregulation of monocyte cyclooxygenase-2 by mediators produced by T lymphocytes: role of interleukin 17 and interferon-gamma. J Rheumatol 31 (2004) 1255-1264
48. Dean J.L., Brook M., Clark A.R., and Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 274 (1999) 264-269
49. Lim M.Y., Wang H., Kapoun A.M., O'connell M., O'Young G., Brauer H.A., et al. p38 inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells. J Mol Cell Cardiol 37 (2004) 1111-1114
50. Hanafusa H., Ninomiya-Tsuji J., Masuyama N., Nishita M., Fujisawa J., Shibuya H., et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression. J Biol Chem 274 (1999) 27161-27167
51. Yang X., Hou F., Taylor L., and Polgar P. Characterization of human cyclooxygenase 2 gene promoter localization of a TGF-beta response element. Biochim Biophys Acta 1350 (1997) 287-292
52. Sheng H., Shao J., Dixon D.A., Williams C.S., Prescott S.M., DuBois R.N., et al. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem 275 (2000) 6628-6635
53. Dibrov A., Kashour T., and Amara F.M. The role of transforming growth factor beta signaling in messenger RNA stability. Growth Factors 24 (2006) 1-11
54. Schmidt-Weber C.B., and Blaser K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 16 (2004) 709-716
55. Okie S. Raising the safety bar-the FDA's coxib meeting. N Engl J Med 352 (2005) 1283-1285